TIDMAZN

RNS Number : 7910Y

AstraZeneca PLC

09 May 2023

   09 May 2023     11:00 BST

Transaction by Person Discharging Managerial Responsibilities

AstraZeneca PLC (the Company) announces that, on 5 May 2023, it was notified of a transaction in the Company's American Depositary Shares (ADSs) by Aradhana Sarin, Chief Financial Officer and Director of the Company, as set out below. Two ADSs are equivalent to one of the Company's ordinary shares of $0.25 each .

 
 PDMR                    Position   Nature of the   Quantity      Price 
                                      transaction 
 Aradhana Sarin   Chief Financial    Sale of ADSs     19,470   US$74.81 
                          Officer 
                 ----------------  --------------  ---------  ---------

Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018.

 
      Details of the person discharging managerial responsibilities 
  1    / person closely associated 
 a)   Name                          Aradhana Sarin 
     ----------------------------  ------------------------------------- 
      Reason for the notification 
  2 
     ------------------------------------------------------------------- 
 a)   Position/status               Chief Financial Officer 
     ----------------------------  ------------------------------------- 
 b)   Initial notification          Initial notification 
       /Amendment 
     ----------------------------  ------------------------------------- 
      Details of the issuer, emission allowance market participant, 
  3    auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                          AstraZeneca PLC 
     ----------------------------  ------------------------------------- 
 b)   LEI                           PY6ZZQWO2IZFZC3IOL08 
     ----------------------------  ------------------------------------- 
      Details of the transaction(s): section to be repeated 
  4    for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of the            AstraZeneca PLC American Depositary 
       financial instrument,         Shares 
       type of instrument 
 
       Identification code           CUSIP: 046353108 
     ----------------------------  ------------------------------------- 
 b)   Nature of the transaction     Sale of AstraZeneca PLC American 
                                     Depositary Shares 
     ----------------------------  ------------------------------------- 
 c)   Price(s) and volume(s)          Price(s)    Volume(s) 
                                        US$74.81      19,470 
                                                  ---------- 
     ----------------------------  ------------------------------------- 
 d)   Aggregated information        Not applicable - single transaction 
 
 
       - Aggregated volume 
 
 
       - Price 
     ----------------------------  ------------------------------------- 
 e)   Date of the transaction       5 May 2023 
     ----------------------------  ------------------------------------- 
 f)   Place of the transaction      XNAS 
     ----------------------------  -------------------------------------

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca .

Contacts

For details on how to contact the Investor Relations Team, please click here . For Media contacts, click here .

Adrian Kemp

Company Secretary

AstraZeneca PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUKVBROBUVRRR

(END) Dow Jones Newswires

May 09, 2023 06:00 ET (10:00 GMT)

Astrazeneca (LSE:0A4J)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024 Haga Click aquí para más Gráficas Astrazeneca.
Astrazeneca (LSE:0A4J)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024 Haga Click aquí para más Gráficas Astrazeneca.